Slim Path Solutions（Winston-Salem, NC）

Slim Path Solutions operates as a telehealth-focused peptide therapy and medical weight loss practice serving patients throughout North Carolina from its Winston-Salem base. Under the direction of Ed Logan, the clinic provides FDA-registered, cGMP-compliant peptide formulations with ACPE-certified oversight, ensuring pharmaceutical-grade quality for every prescription. The practice centers on evidence-based interventions for metabolic optimization, body composition improvement, and age-related hormone decline, delivering structured protocols through virtual consultations that eliminate geographic barriers for North Carolina residents seeking specialized peptide therapy.

Slim Path Solutions offers an extensive peptide therapy program with 5 different peptides available, including metabolic peptides including Semaglutide, Tirzepatide, growth hormone secretagogues like CJC-1295, and other specialized compounds. Treatment selection is individualized based on comprehensive health assessments and patient goals.

Ed Logan structures treatment protocols around measurable outcomes, incorporating baseline metabolic panels, body composition analysis, and ongoing monitoring to adjust peptide dosing and adjunctive interventions. The telehealth model includes video consultations for initial assessments and follow-up appointments, with patients receiving peptides shipped directly from FDA-registered compounding facilities that maintain cGMP standards. This compliance framework addresses the quality concerns that have emerged in the peptide therapy space, providing documentation of third-party testing and sterility verification for each formulation. Patients receive detailed reconstitution instructions, injection technique guidance, and access to clinical support for questions about administration or side effect management throughout their treatment cycle.

The patient experience at Slim Path Solutions begins with a comprehensive intake process that evaluates medical history, current medications, previous weight loss attempts, and hormone-related symptoms such as fatigue, decreased libido, or difficulty maintaining muscle mass. For weight loss candidates, the clinic assesses appropriateness for GLP-1 receptor agonist therapy versus growth hormone secretagogue approaches based on BMI, metabolic health markers, and patient preferences regarding injection frequency and dietary modifications. Hormone optimization patients typically undergo evaluation for growth hormone deficiency indicators before initiating Sermorelin or combination CJC-1295/Ipamorelin therapy, with treatment cycles structured in 12-week intervals followed by reassessment of IGF-1 levels and clinical response markers.

The Winston-Salem clinic’s telehealth-exclusive model serves North Carolina patients who require specialized peptide therapy but lack access to local providers with peptide prescribing experience. Virtual care delivery includes secure messaging for non-urgent questions, prescription management through integrated pharmacy networks, and coordination with patients’ primary care providers when appropriate for lab work or concurrent condition management. Slim Path Solutions maintains its FDA-registered and ACPE-certified status through ongoing compliance audits and provider education, distinguishing the practice in a market where peptide therapy quality and sourcing transparency vary significantly among telehealth providers.